Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹154 Cr₹140 Cr₹114 Cr₹69 Cr₹53 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹154 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr
Mar2021₹69 Cr
Mar2020₹53 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr
66.71
Mar2021 ₹69 Cr
28.51
Mar2020 ₹53 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹747.2 Cr 9.1% 3.2% 27.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

9.1%

3.2%

27.5%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses